HOGY MEDICAL CO.,LTD. (3593) Stock Price

Market cap
P/E ratio
Manufactures medical consumables and nonwoven products like surgical gowns to improve safety in healthcare settings, with strong operations across Southeast Asia.

Price and Volume

Market Cap

Subscribe to premium to access
Market Cap.

Check pricing

PER

Subscribe to premium to access
PER.

Check pricing

PBR

Business Overview

Hogi Medical is a company that manufactures and sells medical consumables, medical devices, and medical nonwoven products. Through these products, the company aims to improve efficiency and safety in medical settings. In particular, medical nonwoven products, such as surgical gowns and drapes, play an important role in infection prevention.

The company's business is composed of Hogi Medical itself and its affiliated companies: P.T. Hogi Indonesia, Hogi Medical Asia Pacific PTE. LTD., and P.T. Hogi Medical Sales Indonesia. These companies handle manufacturing through sales operations, with a particular focus on market expansion in Southeast Asia.

P.T. Hogi Indonesia is responsible for manufacturing medical nonwoven products and certain medical consumables. Meanwhile, Hogi Medical Asia Pacific PTE. LTD. and P.T. Hogi Medical Sales Indonesia conduct sales activities to ASEAN countries, providing products to regional medical institutions. Through this structure, the company strengthens its presence in international markets.

Management Policy

Hogi Medical is committed to advancing healthcare and supporting people's health and well-being. The company provides products and systems that prioritize the safety of patients and healthcare professionals while improving the operational efficiency of medical institutions, thereby contributing to societal prosperity.

Operating in a challenging business environment, the company actively proposes products that maintain medical safety while streamlining operations. In particular, the "Premium Kit" is recognized as a high-value product that reduces procedural steps across surgical stages while ensuring medical safety. Sales of this product are growing steadily.

Under its medium-term management plan through March 2027, the company targets revenue of 46,700 million yen, operating profit of 7,500 million yen, and net profit of 5,600 million yen. The company aims to practice customer-centric value creation and provide solutions that respond to changing customer needs.

As part of its growth strategy, the company is advancing business strategies and product portfolio reforms to maintain sustained high growth. It is strengthening sales capabilities and core business competitiveness while focusing on international business expansion and the creation of new core businesses. The company is also working to improve capital efficiency and enhance shareholder returns.

The company is also transforming its governance structure to enable faster decision-making and strengthen risk management systems. Through these efforts, the company aims to enhance corporate philosophy and enterprise value while achieving sustainable growth.

AI Chat